Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1050 | 1120 | 1156 | 1003 | 1623 | 3107 |
Fund Return | 4.96% | 11.97% | 15.57% | 0.1% | 10.17% | 12% |
Place in category | 2175 | 1228 | 1893 | 1923 | 1034 | 280 |
% in Category | 71 | 42 | 64 | 87 | 61 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Baillie Gifford American Fund B Inc | 2.89B | 3.42 | -12.06 | 16.52 | ||
Baillie Gifford American Fund A Acc | 2.89B | 3.19 | -12.95 | 15.40 | ||
Baillie Gifford American Fund B Acc | 2.89B | 3.39 | -12.08 | 16.52 | ||
Baillie Gifford Global Alpha Growtb | 2.82B | 5.68 | -0.92 | 11.98 | ||
Baillie Gifford Global Alpha Growth | 2.82B | 5.69 | -0.92 | 11.98 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 15.59B | 7.14 | 5.85 | 15.68 | ||
Fundsmith Equity I Inc | 4.68B | 7.14 | 5.85 | 15.68 | ||
Fundsmith Equity R Acc | 613.31M | 6.92 | 5.21 | 14.98 | ||
Fundsmith Equity R Inc | 17.87M | 6.92 | 5.21 | 14.97 | ||
Fundsmith Equity T Acc | 4.24B | 7.10 | 5.74 | 15.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 4.16 | 464.63 | -0.90% | |
Microsoft | US5949181045 | 3.88 | 429.04 | +0.87% | |
Martin Marietta Materials | US5732841060 | 3.82 | 581.31 | -0.31% | |
Amazon.com | US0231351067 | 3.78 | 183.15 | -0.21% | |
Elevance Health | US0367521038 | 3.37 | 546.01 | +0.81% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review